New York, NY, United States of America

Jodd Readick

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • New York, NC (US) (2017)
  • New York, NY (US) (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jodd Readick: Innovator in Cancer Risk Prediction

Introduction

Jodd Readick is a notable inventor based in New York, NY, who has made significant contributions to the field of medical diagnostics. With a total of six patents to his name, Readick is at the forefront of developing innovative methods and systems aimed at predicting the likelihood of cancer in patients.

Latest Patents

Among his latest inventions, Readick has focused on non-invasive methods for predicting cancer risk. His patents detail advanced machine learning systems that utilize biomarkers, such as tumor antigens, alongside clinical parameters gathered from patients. These inventions include a sophisticated classifier generated using machine learning techniques, which analyzes data to assess the likelihood that a patient has cancer. The classifier is trained on retrospective data and evaluates at least two biomarkers and one clinical parameter, ensuring a high degree of sensitivity and specificity in patient classification. This technology represents a significant step forward in personalized medicine and early cancer detection.

Career Highlights

Throughout his career, Jodd Readick has worked with various organizations that value innovation and research in healthcare technology. He has held positions at Paltalk Holdings, Inc. and 2020 Genesystems Inc., where his expertise in developing predictive technologies has contributed to advancements in the field.

Collaborations

Readick's work has been strengthened through collaboration with notable professionals in the industry, including Robert H Nagel and Phillip Eugene Jones. These partnerships have allowed for the pooling of knowledge and resources, further enhancing the impact of their innovative projects.

Conclusion

Jodd Readick's dedication to advancing medical diagnostic technologies showcases his commitment to innovation in the healthcare sector. With his array of patents and collaborative efforts, he is positioned as a key contributor to the future of cancer risk assessment and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…